We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Cracks Down on ‘Pay-for-Delay,’ Charging Slew of Generic Makers
EC Cracks Down on ‘Pay-for-Delay,’ Charging Slew of Generic Makers
July 31, 2012
The European Commission (EC) has accused two brand drugmakers of violating antitrust rules by engaging in “pay-for-delay” agreements with a slew of generic companies, sending both the brand and generic companies Statement of Objections notices.